Ranad Humeidi
Founder and CSO at Omanta (YC S26) | Harvard PhD
Experience
Career
2025Omanta
FounderFounder and Chief Scientific Officer · San Francisco Bay Area · 2025 – Present
2023Broad Institute of MIT and Harvard
Director of the Broad Innovation Fellowship · Cambridge, MA · 2023 – 2025
2020Harvard University
Lead Researcher · Cambridge, MA · 2020 – 2024
2018Broad Institute of MIT and Harvard
Biomedical Researcher - Cancer Program · Golub Lab · 2018 – 2020
2017University of Pennsylvania
Biomedical Researcher - Medical Imaging · Delikatny Lab · 2017
2014The University of Texas at San Antonio
Lead Chemist - MARC Scholar · Doyle Lab · 2014 – 2017
Bio
Co-founder & CSO at Omanta, working with patients to turn frontier science into personalized treatment strategies. Harvard Chemical Biology PhD in 3 years; identified a druggable ulcerative colitis mechanism that led to a multimillion-dollar GSK collaboration. Built and directed a multimillion-dollar rare cancer program for one patient, coordinating researchers, physicians, biotechs, and drug developers. Led strategies for 12+ complex patients after standard options were exhausted.